...R. Fadini; M. Meschia; P.G. Crosignani; L. Falsetti; M. Vignali; P. Ferla; F. Cavagnini; M. Pinto; P. Travaglini; G. Faglia; P. Loli; F. Silvestrini; C. Ferrari; C. Praga; A.E. Pontiroli In a multicentric study, the effect of the antiserotoninergic agent metergoline was evaluated in the management...

...F. Scapin; D. Calistri; G. Tronconi; G. Pellicciotta; S.R. Bareggi; A.E. Pontiroli Metergoline, a prolactin (PRL) lowering drug, is used in the puerperal period to inhibit lactation. Methylergobasine maleate (MEM), widely employed in the puerperium to promote uterine contractions, has also been...

...Carlo Ferrari; Eugenio Reschini; Maddalena Peracchi; Pier Giorgio Crosignani Metergoline is an ergoline derivative with potent peripheral and central antiserotoninergic properties which has recently been shown to possess a marked prolactin (PRL)-lowering activity. This drug significantly decreases...

... acute bromocriptine and metergoline administration. The results of other pituitary function tests were normal. Tomography of the sella turcica and CT scan of the skull were also normal. The patient was treated with metergoline, a prolactin-lowering drug which is believed to act as a serotonin antagonist...

...L. Falsetti; A.M. Voltolini; P.G. Crosignani; G. Lotti; P. Travaglini; G. Faglia; A. Cianci; G. Palumbo; C. Praga; A.E. Pontiroli 84 patients with elevated serum PRL levels, ranging from 25 to 253 ng/ml, were treated with an antiserotonin agent, metergoline, at the dose of 12 mg/day for 90 days...

... investigated, 13 of them lactating puerperae. In the other 15, lactation was prevented by drugs (metergoline in 9, bromocriptine in 6). The women’s serum PRL, FSH, LH, Β-HCG and 17Β-estradiol as well as their FSH and LH response to LHRH (100 µg i.v.) were tested 1,3,7 and 14 days after vaginal delivery. Serum...